APA (7th ed.) Citation

R, S., A, G., A, R., R, M., R, A., M, A., . . . RJ, L. (2018). Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience. Hepatology (Baltimore, Md.), 68(4), 1429. https://doi.org/10.1002/hep.29691

Chicago Style (17th ed.) Citation

R, Salem, et al. "Institutional Decision to Adopt Y90 as Primary Treatment for Hepatocellular Carcinoma Informed by a 1,000-patient 15-year Experience." Hepatology (Baltimore, Md.) 68, no. 4 (2018): 1429. https://doi.org/10.1002/hep.29691.

MLA (9th ed.) Citation

R, Salem, et al. "Institutional Decision to Adopt Y90 as Primary Treatment for Hepatocellular Carcinoma Informed by a 1,000-patient 15-year Experience." Hepatology (Baltimore, Md.), vol. 68, no. 4, 2018, p. 1429, https://doi.org/10.1002/hep.29691.